Release Date: 20/09/12 14:01 Summary: Boardroom Radio Interview Price Sensitive: No Download Document 261.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%